NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the ...
Non-Cell Therapy Achieved 31.4% Adjusted Net Profit Growth Cell Therapy Business Revenue Surged By 7...
* Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, r...
* In the first half of 2021, the Group reported a revenue of approximately USD 229.6 million, a 3...
Strong Momentum across All Business Segments, particularly in Gene & Cell Therapy CDMO Continue to...
NANJING, China, Mar. 30, 2021 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548.HK) today h...
* Reported a revenue of approximately USD 390 million, a 42.9% YoY increase, and a gross profit o...
Highlights: * Revenue of the Group for the year ended December 31, 2020 was approximately ...
NANJING, China, Sept. 17, 2020 /PRNewswire/ -- On September 16th, 2020, GenScript ProBio and REMD B...
NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a lead...
SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Deve...
* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibo...
NANJING, China and SEOUL, South Korea, April 7, 2020 /PRNewswire/ -- GenScript Biotech Corporation'...
NANJING, China, April 1, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a lead...
NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProB...
NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProB...
NANJING, China, Feb. 10, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security...
NANJING, China, Feb. 6, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security ...
NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global ...
SEOUL, South Korea, Dec. 26, 2019 /PRNewswire/ -- On Dec. 23, 2019, at Seoul, South Korea, the CDMO...